Coronary Stent Market- Growth, Trends, and Forecast (2019 - 2024)

Market Overview

The major factors found propelling the growth of the market include the increasing prevalence of coronary artery diseases (CADs), rising the geriatric population, and the technological advancements in coronary stents.

The prevalence of coronary artery disease (CAD) has increased in the past three decades in the low- and middle-income countries, including India. Coronary artery disease is responsible for 20% of the total deaths in India. Thus the burden of CAD has increased and has boosted the usage of coronary stents, thus helping in driving the market growth. In addition, the increasing geriatric population has also increased the demand for coronary stents that is expected to rise over the forecast period.

There has also been a high demand for minimally invasive surgical procedures that is likely to significantly drive the coronary stent market. Thus, there has been a reduction in post-operative trauma and complications with the use of a minimally invasive surgical procedure, which is the major growth driver. Reduced hospital stays and lesser healing time are the other advantages associated with the use of advanced and miniaturized coronary stents.

Scope of the Report

As per the scope of the report, coronary stents are small elastic tubes used for the treatment of narrowed and blocked coronary arteries in patients with coronary artery disease (CAD). These reduce the symptoms of chest pain (angina) and aid in the treatment of a heart attack. These types of stents are also called as heart stents or cardiac stents. They comprise metal mesh and are implanted in constricted coronary arteries during a technique known as percutaneous coronary intervention (PCI) or angioplasty.

Key Market Trends

Drug-eluting Stent is the Largest Segment by Product Type that is Expected to Grow during the Forecast Period

The drug-eluting stent segment has accounted for the largest revenue, as it can be used for the treatment of a large number of disorders, such as diabetes, renal disease, percutaneous coronary intervention, and ST-segment elevation myocardial infarction (STEMI). There are also various technological advances seen in the drug-eluting stent segment that may witness tremendous growth.

North America Experienced the Largest Growth and is Expected to Follow the Same Trend Over the Forecast Period

North America holds the largest market share for coronary stents, due to the dominance of the top companies present in the global market. There is also an increase in the ageing population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as good reimbursement scenario, have been driving the North American coronary stent market.

Competitive Landscape

The major companies have adopted strategies like mergers and acquisitions and strategic alliances to gain a competitive advantage in the market. Additionally, companies are also more focused on the development of technologically advanced products, which deliver greater accuracy and efficiency.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)

4.2.2 Rising of the Geriatric Population

4.2.3 Technological Advancements in Coronary Stents

4.3 Market Restraints

4.3.1 High Product Recalls

4.3.2 Stringent Approval Process for Stents

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product Type

5.1.1 Drug Eluting Stent

5.1.2 Bare Metal Coronary Stent

5.1.3 Bioabsorbable Stent

5.2 By Biomaterial

5.2.1 Metallic Biomaterial

5.2.2 Polymeric Biomaterial

5.2.3 Natural Biomaterial

5.3 By End User

5.3.1 Hospital

5.3.2 Ambulatory Surgical Centre

5.4 Geography

5.4.1 North America

5.4.1.1 United States

5.4.1.2 Canada

5.4.1.3 Mexico

5.4.2 Europe

5.4.2.1 Germany

5.4.2.2 United Kingdom

5.4.2.3 France

5.4.2.4 Italy

5.4.2.5 Spain

5.4.2.6 Rest of Europe

5.4.3 Asia-Pacific

5.4.3.1 China

5.4.3.2 Japan

5.4.3.3 India

5.4.3.4 Australia

5.4.3.5 South Korea

5.4.3.6 Rest of Asia-Pacific

5.4.4 Middle East & Africa

5.4.4.1 GCC

5.4.4.2 South Africa

5.4.4.3 Rest of Middle East & Africa

5.4.5 South America

5.4.5.1 Brazil

5.4.5.2 Argentina

5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Abbott Laboratories

6.1.2 B. Braun Medical Inc.

6.1.3 Biosensors International Group, Ltd.

6.1.4 BIOTRONIK SE & Co. KG

6.1.5 Boston Scientific Corporation

6.1.6 IRIDEX Corporation

6.1.7 Medtronic PLC

6.1.8 Terumo Corporation

6.1.9 Translumina GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

By Product Type

Drug Eluting Stent

Bare Metal Coronary Stent

Bioabsorbable Stent

By Biomaterial

Metallic Biomaterial

Polymeric Biomaterial

Natural Biomaterial

By End User

Hospital

Ambulatory Surgical Centre

Geography

North America

United States

Canada

Mexico

Europe

Germany

United Kingdom

France

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

Middle East & Africa

GCC

South Africa

Rest of Middle East & Africa

South America

Brazil

Argentina

Rest of South America